SEC 13F Intelligence

UNUM THERAPEUTICS INC

CUSIP 903214104

Unum Therapeutics Inc has 26 institutional holders in Filings Flow’s 13F database, together reporting 9.69M shares worth $17M as of Q3 2019.

Institutional Holders
26
Q3 2019
Reported Value
$17M
Ticker
unmapped
private placement or foreign
Quarters Tracked
4

Ownership Trend

Institutional holders
Q4 ’18: 32Q4 ’18Q1 ’19: 38Q1 ’19Q2 ’19: 28Q2 ’19Q3 ’19: 26Q3 ’19filingsflow.com
Total reported value
Q4 ’18: $45MQ4 ’18Q1 ’19: $65MQ1 ’19Q2 ’19: $33MQ2 ’19Q3 ’19: $17MQ3 ’19filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
CAPTRUST FINANCIAL ADVISORS$57.3B AUM—$061Q1 2022

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.